Xoma closes $9.6M deal for rights to Ixinity for hemophilia B
Xoma closed a $9.6 million deal to buy from Aptevo Therapeutics the rights to receive a payment stream for…
Articles by Margarida Maia, PhD
Hemlibra Helps Keep Bleeding Under Control in Babies in HAVEN 7
Preventive treatment with Hemlibra (emicizumab) appears to be safe and helps keep bleeding under control in babies who have…
SerpinPC Found to Ease Bleeding in All Hemophilia Types for 1.5 Years
SerpinPC, a potential treatment for all types of hemophilia, from the drug development pipeline at Centessa Therapeutics, was…
Hemgenix Approved by FDA to Become 1st Gene Therapy for Hem B
The first gene therapy for adults with hemophilia B — branded as Hemgenix (etranacogene dezaparvovec) — has been approved by…
Enzyre Raises €12M to Advance At-home Blood-clotting Test for Hem A
Enzyre has raised €12 million (over $12 million) to speed the development of EnzyPad, a device that could…
Marstacimab Reduces Patients’ Bleeds, Even With Inhibitors
Treatment with marstacimab (PF-06741086), an experimental antibody-based therapy developed by Pfizer, reduced the number of bleeds in patients with…
Blood Test for Factor IX Now Available in Canada, Other Countries
A blood test to determine the amount of active factor IX — the clotting factor that is missing in…
Switch to Kovaltry Seen to Better Protect Boys With Severe Hem A
Boys with severe hemophilia A who switched to Kovaltry (octocog alfa), which replaces a missing clotting protein called…
FDA Places ASC618, Gene Therapy for Hemophilia A, on Fast Track
The U.S. Food and Drug Administration (FDA) has given fast track designation to ASC618, an investigational one-time gene therapy for…
Foam Roller Eased Knee Pain, Improved Range of Motion
A foam roller to release tension in the fascia — a casing of fibrous tissue that surrounds and holds other…